Polyelectrolytic BSA nanoparticles containing silicon dihydroxide phthalocyanine as a promising candidate for drug delivery systems for anticancer photodynamic therapy

• Published in: Journal of biomaterials science. Polymer ed. Vol. 31; no. 11; pp. 1457 - 1474
• Main Authors: Mazzilli, Mariana Ribeiro Farah, Ambrósio, Jéssica Aparecida Ribeiro, da Silva Godoy, Daniele, da Silva Abreu, Alexandro, Carvalho, Janicy Arantes, Junior, Milton Beltrame, Simioni, Andreza Ribeiro
• Format: Journal Article
• Language: English
• Published: England Taylor & Francis 23.07.2020; Taylor & Francis Ltd
• Subjects: BSA; multilayers; Nanoparticles; Nanostructured materials; Photodynamic therapy; polyelectrolyte; silicon(IV) phthalocyanine; BSA; multilayers; polyelectrolyte; photodynamic therapy; silicon(IV) phthalocyanine
• ISSN: 0920-5063; 1568-5624
• DOI: 10.1080/09205063.2020.1760702

Recently several scientific-technological advances in the health area have developed. Among them, we can highlight research addressing nanoscience and nanotechnology focusing on the development of formulations for the cancer treatment. This work describes the synthesis and characterization of bovine serum albumin (BSA) polyelectrolytic nanoparticles for controlled release using silicon dihydroxide phthalocyanine [SiPc (OH) 2 ] as a photosensitizer model for application in Photodynamic Therapy (PDT). BSA nanoparticles were prepared by the one-step desolvation process and the nanoparticulate system was coated with polyelectrolytes using poly-(4-styrene sulfonate - PSS) as a strong polyanion and polyallylamine hydrochloride (PAH) as a weak polycation by the technique self-assembling layer-by-layer (LbL). The formulation was characterized and available in cellular culture. The profile of drug release was investigated and compared to that of free [SiPc (OH) 2 ]. The nanoparticles have a mean diameter of 226.9 nm, a narrow size distribution with polydispersive index of 0.153, smooth surface and spherical shape. [SiPc(OH) 2 ] loaded nanoparticles maintain its photophysical behaviour after encapsulation. The polyelectrolytic nanoparticles improved efficiency in release and photocytotoxicity assay when compared to pure drug. The results demonstrate that photosensitizer adsorption on BSA nanoparticles together with biopolymer layer-by-layer assembly provides a way to manufacture biocompatible nanostructured materials that are intended for use as biomaterials for Photodynamic Therapy applications.